B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humans

Pascual-Figal, Domingo A.; Antolinos, Maria J.; Bayes-Genis, Antoni; Casas, Teresa; Nicolas, Francisco; Valdés, Mariano
September 2007
Heart;Sep2007, Vol. 93 Issue 9, p1077
Academic Journal
Background: The association between B-type natriuretic peptide (BNP) and coronary artery disease is not fully understood. Objective: To assess whether ischaemia per se is a stimulus for BNP secretion. Setting: University tertiary hospital, Spain (Virgen de Ia Arrixaca). Design: Prospective interventional study. Patients: 11 patients (55 (9) years, left ventricular ejection fraction (LVEF) 45% (7%) with a non-complicated anterior myocardial infarction (MI) and isolated stenosis of the left anterior descending (LAD) coronary artery, successfully treated by primary angioplasty. Interventions: 11.0 (0.9) days after MI, the LAD was occluded (20 min) for intracoronary infusion of progenitor cells. Blood samples were obtained from the femoral artery (peripheral circulation (PC)) and the coronary sinus (coronary circulation (CC)) immediately before and after coronary occlusion. Main outcome measures: BNP (pg/mI) was measured and ischaemia biomarkers were monitored. Results: During coronary occlusion, all patients experienced transitory chest pain and ST-segment dynamic changes. After coronary occlusion, lactic acid levels rose in CC (1.42 (0.63) -1.78 (0.68) ng/ml, p=0.003). Myoglobin and cardiac troponin T did not differ in CC or PC at 24 h. No differences were found in LVEF (+0.18% (2.4)%, p=0.86) and motion score index (-0.02 (0.06), p=0.37). Before occlusion, BNP levels did not differ significantly in CC versus PC (253 (56) vs 179 (34), p=0.093). After occlusion, BNP showed a significant increase in CC (vs 332 (61), p=0.004), but no change occurred in PC (vs 177 (23), p=0.93), and circulating BNP levels were higher in CC versus PC (p=0.008). Conclusions: In response to acute ischaemia, BNP levels immediately increase in coronary sinus but not at the peripheral level. BNP release in the coronary effluent may exert local beneficial effects.


Related Articles

  • BNP predicts prognosis.  // Pulse;3/27/2008, Vol. 68 Issue 11, p6 

    The article reports on the findings of a study conducted by German researchers regarding the role of brain natriuretic peptide (BNP). The researchers examined 2,614 patients from two separate registries with evidence of acute coronary syndrome. Based on the results, they concluded that testing...

  • Journal Watch.  // Pulse;11/16/2006, Vol. 66 Issue 43, p20 

    The article offers world news briefs from several periodicals on various medical research. An Australian study concludes that cognitive behavioral therapy can improve quit rates among smokers with a psychotic disorder. A Swiss study showed that B-type natriuretic peptide testing predicts...

  • BNP testing uncovers hidden heart disease.  // GP: General Practitioner;5/5/2006, p9 

    This article reports on a research study conducted by Nigel Rowell, a heart specialist, which revealed that the B-type natriuretic peptide (BNP) test should be used for detecting previously unrecognized heart disease as well as confirming suspected heart failure. He told that BNP is a marker for...

  • BNP: Not Just for Heart Failure. Kuritzky, Louis // Internal Medicine Alert;2/28/2007, Vol. 29 Issue 4, p32 

    The article focuses on a study which examined the link between brain natriuretic peptide and coronary heart disease in patients with stable heart disease.

  • Cardiovascular Disease Risk. Williams, David S. // Journal of Insurance Medicine;2005, Vol. 37 Issue 2, p169 

    Presents an abstract of the study "N-Terminal Pro-B Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease," by C. Kragelund, L. Kober.

  • Involvement of the atrial natriuretic peptide in cardiovascular pathophysiology and its relationship with exercise.  // International Archives of Medicine;2012, Vol. 5 Issue 1, p4 

    The article offers information on a research that studies the relationship between atrial natriuretic peptides (ANP)and cardiovascular pathophysiology and the role of exercise. It is mentioned that ANP exerts homeostatic properties and affects the cardio-circulatory hemodynamics. Also, ANP is...

  • Association of 2238T>C Polymorphism of the Atrial Natriuretic Peptide Gene With Coronary Artery Disease in Afro-Caribbeans With Type 2 Diabetes. Larifla, Laurent; Maimaitiming, Suriya; Velayoudom-Cephise, Fritz-Line; Ferdinand, Severine; Blanchet-Deverly, Anne; BenAbdallah, Sonia; Donnet, Jean-Paul; Atallah, André; Roussel, Ronan; Foucan, Lydia // American Journal of Hypertension;May2012, Vol. 25 Issue 5, p524 

    BackgroundThe atrial natriuretic peptide (ANP) is known mainly for its effects on kidney function and blood pressure homeostasis. We investigated the association between two ANP polymorphisms and pre-existing coronary artery disease (CAD) in patients of African descent with type 2 diabetes...

  • Natriuretic peptide and diastolic heart failure in the elderly. Macarie, Antonia; Vesa, Ştefan C. // Human & Veterinary Medicine;Aug2009, Vol. 1 Issue 1, p37 

    Objective: To determine the possible correlation of amino-terminal pro B natriuretic peptide (NT-proBNP) and other factors with the diastolic dysfunction (DD) in elderly diagnosed with heart failure (HF). Material and methods: 87 Patients aged over 65 years, diagnosed with HF, were included in...

  • Atrial natriuretic peptide reduces hepatic ischemia–reperfusion injury in rabbits. Yamada, Takashige; Kotake, Yoshifumi; Nagata, Hiromasa; Takeda, Junzo // Journal of Anesthesia;Dec2013, Vol. 27 Issue 6, p901 

    Purpose: Atrial natriuretic peptide (ANP) has been known to be protective against hepatic ischemia/reperfusion injury. The purpose of this study was to verify the hypothesis that ANP conserves microvascular circulation and reduces ischemia–reperfusion injury in the in vivo rabbit model....


Read the Article


Sign out of this library

Other Topics